Share on StockTwits
 

Amsurg Corp. (NASDAQ:AMSG) issued its quarterly earnings data on Tuesday. The company reported $0.60 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.57 by $0.03, ARN reports. The company had revenue of $284.60 million for the quarter, compared to the consensus estimate of $283.54 million. Amsurg Corp. updated its Q1 guidance to $0.53-0.57 EPS and its FY14 guidance to $2.45-2.49 EPS.

A number of research firms have recently commented on AMSG. Analysts at Zacks reiterated a “neutral” rating on shares of Amsurg Corp. in a research note on Thursday, January 2nd. They now have a $48.00 price target on the stock. Analysts at Sidoti initiated coverage on shares of Amsurg Corp. in a research note on Monday, December 9th. They set a “neutral” rating on the stock. Six research analysts have rated the stock with a hold rating, The company currently has a consensus rating of “Hold” and an average target price of $44.80.

Amsurg Corp. (NASDAQ:AMSG) traded down 1.82% on Tuesday, hitting $42.12. 97,084 shares of the company’s stock traded hands. Amsurg Corp. has a 52 week low of $29.02 and a 52 week high of $48.71. The stock has a 50-day moving average of $43. and a 200-day moving average of $42.51. The company has a market cap of $1.357 billion and a P/E ratio of 19.62.

AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.